Belpointe Asset Management LLC Heron Therapeutics, Inc. Transaction History

Belpointe Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$2.25 - $4.67 $234 - $485	104 New	104 $0
Q1 2021 May 14, 2021	SELL	$14.49 - $20.72 $114,050 - $163,087	-7,871 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$14.61 - $22.14 $93,927 - $142,338	-6,429 Reduced 44.96%	7,871 $166,000
Q3 2020 Nov 13, 2020	SELL	$13.67 - $17.77 $15,037 - $19,547	-1,100 Reduced 7.69%	13,200 $155,000
Q3 2020 Nov 13, 2020	BUY	$13.67 - $17.77 $15,037 - $19,547	1,100 Added 8.33%	14,300 $212,000
Q2 2020 Jul 20, 2020	BUY	$10.89 - $21.47 $11,979 - $23,617	1,100 Added 8.33%	14,300 $210,000
Q1 2020 Jul 20, 2020	SELL	$10.23 - $24.56 $26,598 - $63,856	-2,600 Reduced 16.46%	13,200 $155,000
Q3 2019 Jan 16, 2020	BUY	$16.36 - $21.39 $39,378 - $51,485	2,407 Added 17.97%	15,800 $292,000
Q2 2019 Nov 22, 2019	BUY	$16.93 - $26.22 $3,267 - $5,060	193 Added 1.46%	13,393 $0
Q1 2019 Jun 11, 2019	BUY	$23.15 - $28.34 $305,580 - $374,088	13,200 New	13,200 $323,000

174

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $207M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.